IL-16 represses HIV-1 promoter activity.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 8977168)

Published in J Immunol on January 01, 1997

Authors

J W Maciaszek1, N A Parada, W W Cruikshank, D M Center, H Kornfeld, G A Viglianti

Author Affiliations

1: The Program in Virology and Immunology, University of Massachusetts Medical Center, Worcester 01605, USA.

Articles citing this

Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology (2007) 1.77

Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro. J Virol (1998) 1.39

Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France. Clin Exp Immunol (2007) 1.19

An African green monkey lacking peripheral CD4 lymphocytes that retains helper T cell activity and coexists with SIVagm. Clin Exp Immunol (1999) 1.02

Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells. J Virol (1999) 0.89

The synthetic immunomodulator murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells. J Virol (2000) 0.89

Recombinant human IL-16 inhibits HIV-1 replication and protects against activation-induced cell death (AICD). Clin Exp Immunol (1998) 0.88

Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor. Blood (2005) 0.88

Human B-cell lines constitutively express and secrete interleukin-16. Immunology (2000) 0.86

Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation. J Neuroimmune Pharmacol (2010) 0.85

Inhibitory effect of interleukin-16 on interleukin-2 production by CD4+ T cells. Immunology (1999) 0.84

HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads. Front Microbiol (2015) 0.80

HIV-1 infection is facilitated in T cells by decreasing p56lck protein tyrosine kinase activity. Clin Exp Immunol (2003) 0.79

Modulation of HIV transcription by CD8(+) cells is mediated via multiple elements of the long terminal repeat. Clin Exp Immunol (2001) 0.75

CD8+ T cell-mediated enhancement of tumour necrosis factor-alpha (TNF-alpha) production and HIV-1 LTR-driven gene expression in human monocytic cells is pertussis toxin-sensitive. Clin Exp Immunol (1999) 0.75

Articles by these authors

Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol (2000) 3.19

Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun (1997) 2.85

T-lymphocyte subpopulations in homosexual men. N Engl J Med (1982) 2.72

Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses. Nature (1987) 2.61

Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J Immunol (1998) 2.55

Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immun (1997) 2.16

Lymphocyte activation by HIV-1 envelope glycoprotein. Nature (1988) 2.15

Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr (1992) 1.95

Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J Immunol (1982) 1.92

Alteration of hsp82 gene expression by the gypsy transposon and suppressor genes in Drosophila melanogaster. Genes Dev (1989) 1.73

Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. Cancer Res (1989) 1.73

A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc Natl Acad Sci U S A (1997) 1.67

Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci U S A (1994) 1.65

Interleukin-16. J Leukoc Biol (2000) 1.59

CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J Exp Med (1991) 1.58

Lymphokine activation of T4+ T lymphocytes and monocytes. J Immunol (1987) 1.58

Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect Immun (1994) 1.57

Macrophage apoptosis in mycobacterial infections. J Leukoc Biol (1999) 1.51

Vbeta8+ T lymphocytes are essential in the regulation of airway hyperresponsiveness and bronchoalveolar eosinophilia but not in allergen-specific IgE in a murine model of allergic asthma. Clin Exp Allergy (1998) 1.43

Regulation of endothelial cell glyceraldehyde-3-phosphate dehydrogenase expression by hypoxia. J Biol Chem (1994) 1.38

Lymphocyte recruitment to the lung. Am Rev Respir Dis (1990) 1.37

Induction of human T lymphocyte motility by interleukin 2. J Immunol (1985) 1.35

Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge. J Clin Invest (1977) 1.34

Interleukin 16 and its function as a CD4 ligand. Immunol Today (1996) 1.34

Processing and activation of pro-interleukin-16 by caspase-3. J Biol Chem (1998) 1.34

TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-gamma independent manner. Tuberculosis (Edinb) (2002) 1.33

Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J Immunol (1997) 1.32

Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF). J Immunol (1982) 1.31

Expansion of a CD8+CD28- cell population in the blood and lung of HIV-positive patients. J Acquir Immune Defic Syndr (1993) 1.30

Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro. J Immunol (1992) 1.28

Human eosinophils express functional interleukin 2 receptors. J Clin Invest (1991) 1.26

Nitrogen Turnover and Assimilation during Regrowth in Trifolium subterraneum L. and Bromus mollis L. Plant Physiol (1983) 1.25

Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol (1996) 1.20

Histamine-induced secretion of lymphocyte chemoattractant factor from CD8+ T cells is independent of transcription and translation. Evidence for constitutive protein synthesis and storage. J Immunol (1995) 1.18

Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein. Proc Natl Acad Sci U S A (1992) 1.18

Increased expression of interleukin-16 in bronchial mucosa of subjects with atopic asthma. Am J Respir Cell Mol Biol (1997) 1.16

Evolution of a simian immunodeficiency virus pathogen. J Virol (1998) 1.15

Induction of human monocyte motility by lysyl oxidase. Matrix Biol (1995) 1.12

IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation. J Immunol (1996) 1.10

Cultured human fibroblasts express constitutive IL-16 mRNA: cytokine induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism. J Immunol (2000) 1.09

Synergistic activation of CD4+ T cells by IL-16 and IL-2. J Immunol (1998) 1.09

CD4 ligand IL-16 inhibits the mixed lymphocyte reaction. J Immunol (1996) 1.08

B lymphocyte-derived IL-16 attracts dendritic cells and Th cells. J Immunol (2000) 1.07

Cross-reactivity to human T-lymphotropic virus type III/lymphadenopathy-associated virus and molecular cloning of simian T-cell lymphotropic virus type III from African green monkeys. Proc Natl Acad Sci U S A (1986) 1.06

Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset. Cell Immunol (1985) 1.06

Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol (1997) 1.05

Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro. J Clin Invest (1988) 1.05

Lymphocyte motility and lymphocyte chemoattractant factors. Immunol Invest (1989) 1.04

A role for IL-16 in the cross-talk between dendritic cells and T cells. J Immunol (1999) 1.04

Chemokine and matrix metalloproteinase secretion by myelin proteolipid protein-specific CD8+ T cells: potential roles in inflammation. J Immunol (1997) 1.02

Pulmonary presentation of Kaposi's sarcoma in a homosexual patient. Am Rev Respir Dis (1983) 1.01

Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis. J Allergy Clin Immunol (1998) 1.01

Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis. J Immunol (1999) 1.00

Tissue and T cell distribution of precursor and mature IL-16. J Immunol (1998) 0.99

Involvement of IL-16 in the induction of airway hyper-responsiveness and up-regulation of IgE in a murine model of allergic asthma. J Immunol (1998) 0.99

Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (1999) 0.97

Processing and release of IL-16 from CD4+ but not CD8+ T cells is activation dependent. J Immunol (1999) 0.97

The CD4-associated tyrosine kinase p56lck is required for lymphocyte chemoattractant factor-induced T lymphocyte migration. J Biol Chem (1995) 0.97

Interleukin 16: implications for CD4 functions and HIV-1 progression. Immunol Today (2000) 0.97